Professional Documents
Culture Documents
By Dr Maria Naeem
Poliomyelitis
Polio
• Acute viral infection caused by RNA virus.
• Primarily a GIT infection.
• In 1% of cases, it affects CNS.
Problem statement
• In pre-vaccination era – polio virus used to be
found in all countries of the world.
• 1988 – World Health Assembly adopted
resolution for the global eradication of polio.
• 1994 – Americas was the first to be announced
as polio-free.
• 2002 – Europe certified polio-free.
• 2014 – Only Three countries in the world left
where Polio is still endemic.
Polio eradication and endgame
strategic plan (2013-2018)
• The plan has 4 objectives:
1) Detect and interrupt all polio transmission.
2) Strengthen immunization system and
withdraw OPV.
3) Containment and certification.
4) Legacy planning.
Agent factors
• Agent – Poliovirus, three serotypes 1, 2 , 3. Most
outbreaks of paralytic polio are due to type -1.
• Transmission – faecal-oral route. In cold environment,
survives in water for 4 months and in faeces for 6
months.
• Reservoir – Man is the only reservoir. Most infections
subclinical which play a major role in spread of infection.
• Infectious material – Virus is found in faeces and
oropharyngeal secretions.
• Period Of Communicability – 7 to 10 days before and
after onset of symptoms.
Host factors
• Age – Essentially a disease of infancy and
childhood.
• Sex – ratio of 3 males to one female.
• Risk Factors – fatigue, trauma, intramuscular
injections, operative procedures.
• Immunity: maternal antibodies gradually
disappear during 6 months of life.
Environmental factors
• Polio is more likely to occur during the rainy
season (June to September).
• Environmental sources of infection are
contaminated water, food and flies.
• Polio virus survives for a long time in a cold
environment.
• Overcrowding and poor sanitation provide
opportunities for exposure to infection.
Polio
• Mode of transmission – faecal-oral route,
spreads through infected fingers, contaminated
water, milk, food, flies; droplet infection.
• Incubation Period – 7 to 14 days (range 3 to
35 days).
Clinical spectrum
Clinical spectrum
• Subclinical (Inapparent) infection – 95% of
poliovirus infection.No presenting symptoms.
• Abortive Polio(Minor illness) – occurs in 4 to
8% of polio infections, self-limiting.
• Non-paralytic Polio – Occurs in 1% of cases,
stiffness and pain in the neck and back.
Recovery is rapid.Disease lasts 2-10 days.
• Paralytic Polio – Occurs in less than 1% of
infections. Weakness of muscle or muscle
groups (flaccid paralysis).
Other associated symptoms:
• Malaise
• Anorexia
• Nausea,Vomiting
• Headache,Sore throat,Constipation
• Signs of meningeal irritation(stiffness if neck
and back muscles)
• Tripod sign:Child finds difficulty in sitting and
sits by supporting hand at the back.By partly
flexing the hips and knees.
Paralytic polio
Treatment
• No cure.
• Supportive treatment – good nursing care,
non-narcotic analgesics, hydration and proper
nutrition, respiratory support.
• Can only be prevented by immunization.
Prevention
• Immunization
OPV(oral polio vaccine) – called Sabin, easy
to give, cheaper, more effective, produces both
intestinal and systemic immunity.
IPV (injectable polio vaccine) - costly, given
parenterally, produces only systemic
immunity, trained persons required for its
administration.
Oral Polio Vaccine (OPV)
• It is recommended that OPV should be stored at -20
degree centigrade, but certain vaccine brands can
remain effective between the temperature of 2 to 8
degree centigrade.
• As the rural areas of Pakistan are suffering from regular
load shedding of 12-18 hours, this can affect the
storage of OPV.
Epidemiological investigations
• The occurrence of a single case of polio is now
considered as an epidemic.
• Sample of faeces from all cases or suspected
cases.
POLIO - WORLD VS PAKISTAN